CLP Magazine recently hosted a webinar on the rise of full-field cell morphology and the all-digital workflow. Watch the webinar—which is sponsored by Scopio Labs—here.
Full-field cell morphology represents significant progress in standardization, efficiency, remote workflow capability, and scalability of hematological examination. It fundamentally changes laboratory practice and closes the gap between the manual and digital peripheral blood smear review.
Olga Pozdnyakova, MD, PhD, associate professor of pathology, Harvard Medical School, Medical Director, Hematology Laboratory, Brigham and Women’s Hospital; and Benzi Katz, PhD, director, Hematology Lab, Tel Aviv Medical Center, detailed the technology being developed at Scopio Labs to webinar attendees.
Additionally, Pozdnyakova and Katz discussed during the webinar the results of a multi-institutional FDA clinical trial, including representative full-field blood smear scans, simulating comprehensive morphology analysis of real-life blood smears, and the clinical benefits of this digital approach.
Katz shared his experience using this technology at the Tel Aviv Sourasky Medical Center with specific emphasis on its overall clinical performance and advantages over the current technologies. Also, Pozdnyakova presented research data measuring cell morphologic changes in myelodysplastic syndrome using Scopio AI-based analysis and introduce attendees to innumerable and fascinating research opportunities.